Articles tagged as

Drug Manufacturers - Major

  1. The 5 Best Dividend Stocks in the Healthcare Sector

  2. Top 5 Health Mutual Funds

  3. Should You Avoid Biotech Stocks Right Now?

  4. 4 Trends Driving M&A in the Healthcare Industry in 2015

  5. Are Drug Price Controls Viable in the U.S.?

  6. ETF Analysis: Direxion Daily Healthcare Bull 3X

  7. Healthcare M&A and Prescription Drug Prices

  8. Valeant Pharmaceuticals acquires Sprout Pharmaceuticals

  9. ETF Analysis: PowerShares Dynamic Pharmaceuticals

  10. Is the Ebola Epidemic Officially Over?

  11. Sarepta Therapeutics Made Investors Millionaires in 2 Years

  12. Celgene Vs. Gilead: Vetting for the Best Biopharma

  13. Make Room for Exelixis in Your Portfolio

  14. Drugmaker Extraordinaire: How Eli Lilly Grows

  15. ETF Analysis: Market Vectors Pharmaceutical

  16. Are Bears About to Burst the Biotech Bubble?

  17. Pfizer CEO: The Story Behind Ian Read

  18. 10 Developments By Gilead Sciences That Could Boost Profits

  19. Are These 2015's 10 Best Generic Pharma Stocks?

  20. How to Profit from the Generic Drug Trend

  21. From Startup To Blue Chip: The Success Story Of Gilead Sciences Inc.

  22. Top 10 Pfizer Venture Investments

  23. Is It Too Late To Invest In Gilead Sciences?

  24. How Does Biogen Make its Money?

  25. Small-Cap Biotech Stocks to Watch

  26. Are These the Top 3 Value Stocks of 2015?

  27. 3 Top Pharma Stocks that Pay Regular Dividends

  28. How to Analyze Pharma Stock Fundamentals

  29. How Bristol-Myers Squibb Makes the World Healthier

  30. How is a Spinoff Worth $100 Billion? See AbbVie

  31. Why These Could Be 2015's 10 Best Biotech Stocks

  32. Why These Could Be 2015's 10-Best Pharma Stocks

  33. Why These ETFs are the Best Way to Trade Pfizer

  34. Could Amgen's Next Drug Be Worth $100 Billion?

  35. Has The Time Come To Sell Vertex Pharmaceuticals?

  36. Why Celgene Won't Pay A Dividend Anytime Soon

  37. Could This Drug Make Isis Pharmaceuticals Soar?

  38. What Biotech Stock To Buy When The Market Tumbles?

  39. Did Orexigen Make A Big Mistake?

  40. Are These Biogen Idec's Next Blockbusters?

  41. Why Does Wall Street Hate MannKind?

  42. Is Exelixis Under-the-Radar Growth?

  43. Is Arena Pharmaceuticals In Trouble?

  44. What’s The Drug That Will Finally Fight Obesity?

  45. Should You Invest In Oraganovo Holdings?

  46. What Is Amgen’s New Target?

  47. Will MannKind Finally Reach A Solid Ground?

  48. Should We Be Concerned For Sarepta’s Share Prices?

  49. What Are The Real Economic Costs Of Obesity?

  50. Gilead Sciences: The New Market-Share Leader

  51. Sun Pharma And Ranbaxy: An Ideal Pharma Marriage?

  52. Dilip Shanghvi's Net Worth: How Did He Get So Rich?

  53. How Amgen Makes Billions On Just A Few Drugs

  54. How Merck Found Its Way Into Millions Of Medicine Cabinets

  55. How Gilead Sciences Became A Big Name In Biotech

  56. Want To Make Money In Marijuana? Read This First

  57. What Are The Best Bets In Biotech?

  58. How Some Brands Come Back from Near Death

  59. It's No Accident That Drugs Are Expensive

  60. Will Immunotherapy Disrupt The Oncology Market?

  61. 8 Stages Of New Drug Development

  62. Big Pharma Faces 'Pay For Delay' Lawsuits

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!